96
Participants
Start Date
February 4, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
ND-003 tablets
ND-003 tablets will be administered orally and observe 4 days, and followed by over continuous 28-days cycles.
ND-003 tablets
ND-003 tablets will be administered orally and observe 4 days, and followed by over continuous 28-days cycles.
ND-003 tablets
ND-003 tablets will be administered orally and observe 4 days, and followed by over continuous 28-days cycles.
ND-003 tablets
ND-003 tablets will be administered orally and observe 4 days, and followed by over continuous 28-days cycles.
ND-003 tablets
ND-003 tablets will be administered orally and observe 4 days, and followed by over continuous 28-days cycles.
ND-003 tablets
ND-003 tablets will be administered orally and observe 4 days, and followed by over continuous 28-days cycles.
ND-003 tablets
ND-003 tablets will be administered orally over continuous 28-days cycles.
ND-003 tablets
ND-003 tablets will be administered orally over continuous 28-days cycles.
the First Affiliated Hospital of Xiamen University, Xiamen
Gansu Provincial Cancer Hospital, Lanzhou
the first hospital of Lanzhou University, Lanzhou
Sun Yat-sen University cancer center, Guangzhou
The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen
Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang
Guangxi Medical University Cancer Hospital, Nanning
the Affiliated Hospital of Guizhou Medical University, Guiyang
Tongji Hospital Tongji Medical College of HUST, Wu’an
Hunan Cancer Hospital, Changsha
Jiangxi Cancer Hospital, Nanchang
The First Hospital of China Medical University, Shenyang
General Hospital of Ningxia Medical University, Yinchuan
Shandong Cancer Hospital & Institute, Jinan
Linyi Cancer Hospital, Linyi
Sichuan Cancer Hospital, Chengdu
The Second People's Hospital of Neijiang, Neijiang
Tianjin Medical University Cancer Institute & Hospital, Tianjin
Yunnan Cancer Hospital, Kunming
Sir Run Run Shaw Hospital, Hangzhou
Shenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.
UNKNOWN
Sun Yat-sen University
OTHER
Shenzhen NewDEL Biotech, Co., Ltd
INDUSTRY